Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-30
2009-06-30
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S028000
Reexamination Certificate
active
07553866
ABSTRACT:
This invention provides new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, inhibiting angiogenesis, effecting a TGF-β activity or a neuronal activity, and treating a glutamate abnormality, a compulsive disorder, neuropathy, pain, a prostate disease, cancer, Huntington's disease, diabetes, a retinal disorder or glaucoma.
REFERENCES:
patent: 4239636 (1980-12-01), Brois et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5824662 (1998-10-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5977090 (1999-11-01), Slusher et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 5985855 (1999-11-01), Slusher et al.
patent: 6004946 (1999-12-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6028216 (2000-02-01), Morales et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6071965 (2000-06-01), Jackson et al.
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6228888 (2001-05-01), Slusher
patent: 6265609 (2001-07-01), Jackson et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: 6288046 (2001-09-01), Jackson et al.
patent: 6313159 (2001-11-01), Jackson et al.
patent: 6348464 (2002-02-01), Jackson et al.
patent: 6372726 (2002-04-01), Slusher et al.
patent: 6376478 (2002-04-01), Slusher
patent: 6384022 (2002-05-01), Jackson et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6413948 (2002-07-01), Slusher et al.
patent: 6444657 (2002-09-01), Slusher et al.
patent: 6452044 (2002-09-01), Jackson et al.
patent: 6458775 (2002-10-01), Jackson et al.
patent: 6479471 (2002-11-01), Jackson et al.
patent: 6586623 (2003-07-01), Tsukamoto et al.
patent: 6740777 (2004-05-01), Tsukamoto et al.
patent: 6812364 (2004-11-01), Tsukamoto et al.
patent: 7125907 (2006-10-01), Slusher et al.
patent: 2003/0017965 (2003-01-01), Slusher et al.
patent: 2003/0036534 (2003-02-01), Slusher et al.
patent: 2003/0064912 (2003-04-01), Slusher et al.
patent: 2003/0083374 (2003-05-01), Jackson et al.
patent: 2003/0083505 (2003-05-01), Jackson et al.
patent: 2003/0087897 (2003-05-01), Tsukamoto et al.
patent: 2003/0216468 (2003-11-01), Tsukamoto et al.
patent: 2004/0186081 (2004-09-01), Slusher et al.
patent: 2004/0198824 (2004-10-01), Tsukamoto et al.
patent: 2434117 (2002-07-01), None
patent: 2 819 253 (2002-07-01), None
patent: WO 94/05687 (1994-03-01), None
patent: WO 01/01974 (2001-01-01), None
patent: WO 01/91738 (2001-12-01), None
patent: WO 02/057222 (2002-07-01), None
Collins,Expert Opin. Emerging Drugs10(1):95-108 (2005).
Derwent WPI Abstract (English language Absract) for FR 2 819 253.
Hannessian et al., “N-Aryl Sulfonyl Homocysteine Hydroxamate Inhibitors of Matrix Metalloproteinases”,J. Med. Chem. 44:3066-3073 (2001).
International Search Report (PCT/US2004/006178).
Jackson et al., “Design of NAALADase Inhibitors: A Novel Neuroprotective Strategy”,Current Medicinal Chemistry8:949-957 (2001).
Morissette et al., “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids”,Advanced Drug Delivery Reviews56:275-300 (2004).
Takahata et al., “Regloselective Thio-Claisen Rearrangement”,Heterocycles24(12):3347-3350 (1986).
Tokmakov, “α-Dimethylaminomethylene-γ-Thiobutyrolactone and Synthesis of Heterocyclic Derivatives”,Chemistry of Heterocycle Compounds32(2) (1996).
European Search Report, European Application No. 08 01 3761 (European Published Application No. EP 1 988 088 A1), Sep. 23, 2003 (3 pages), herewith.
Slusher Barbara S.
Tsukamoto Takashi
Anderson Rebecca L
Arnold & Porter LLP
Eisai Corporation of North America
Nolan Jason
LandOfFree
Thiolactones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiolactones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiolactones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4144461